CAS No. |
21586-90-3 |
中文名称 |
(1R,2S,3R,3aR,3a1R,4R,6aR,7aS,10S,11S,11aS,11bR)-1,2,3a,4,10,11-六羟基-3,8,11a-三甲基-1,2,3,3a,4,6a,7,7a,10,11,11a,11b-十二氢-5H-3,3a1-(环氧甲桥)二苯并[de,g]苯并吡喃-5-酮 |
英文名称 |
(1R,2S,3R,3aR,3a1R,4R,6aR,7aS,10S,11S,11aS,11bR)-1,2,3a,4,10,11-Hexahydroxy-3,8,11a-trimethyl-1,2,3,3a,4,6a,7,7a,10,11,11a,11b-dodecahydro-5H-3,3a1-(epoxymethano)dibenzo[de,g]chromen-5-one |
别名 |
13,20-Epoxy-1β,2α,11β,12α,14,15β-hexahydroxypicras-3-en-16-one;20-Deoxybruceine F;2-O-Demethylbruceine M;Brucein E;Picras-3-en-16-one, 13,20-epoxy-1,2,11,12,14,15-hexahydroxy-, (1β,2α,11β,12α,15β)-;(1R,2S,3R,3aR,3a1R,4R,6aR,7aS,10S,11S,11aS)-1,2,3a,4,10,11-hexahydroxy-3,8,11a-trimethyl-2,3,3a,4,7,7a,10,11,11a,11b-decahydro-1H-3,3a1-(epoxymethano)dibenzo[de,g]chromen-5(6aH)-one;hypoglycemia,quassinoid,Bruceine E,effect,Inhibitor,antidiabetic,inhibit;(1R,2S,3R,3aR,3a1R,4R,6aR,7aS,10S,11S,11aS,11bR)-1,2,3a,4,10,11-Hexahydroxy-3,8,11a-trimethyl-1,2,3,3a,4,6a,7,7a,10,11,11a,11b-dodecahydro-5H-3,3a1-(epoxymethano)dibenzo[de,g]chromen-5-one |
标准英文名 |
(1R,2S,3R,3aR,3a1R,4R,6aR,7aS,10S,11S,11aS,11bR)-1,2,3a,4,10,11-hexahydroxy-3,8,11a-trimethyl-1,2,3,3a,4,6a,7,7a,10,11,11a,11b-dodecahydro-5H-3,3a1-(epoxymethano)dibenzo[de,g]chromen-5-one |
分子式 |
C20H28O9 |
分子量 |
412.43
|
精确分子量 |
412.17
|
SMILES |
CC1=C[C@H](O)[C@@H](O)[C@]2(C)[C@H]3[C@@H](O)[C@H](O)[C@@]4(C)OC[C@@]35[C@@H](C[C@@H]12)OC(=O)[C@H](O)[C@]54O |
标准SMILES |
CC1=C[C@H](O)[C@@H](O)[C@@]2(C)[C@H]1C[C@H]1OC(=O)[C@H](O)[C@]3(O)[C@@]41CO[C@]3(C)[C@@H](O)[C@H](O)[C@H]24 |
用途 |
Treatment of malignant tumors; antimalarial activity; anti-inflammatory activity; hypoglycemic effect (antidiabetic). |
InChIKey |
ZBXITHPYBBXZRG-QYUWQHSUSA-N |